On a clinical level, the study suggests that physicians prescribing Lumakras should remain vigilant for early signs of ILD, especially in patients with lung comorbidities. Additionally, biomarker ...
RA-ILD has worse outcomes than RA and is most likely in those with extra-articular RA manifestations and in those who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback